SUBSCRIBE
SUBSCRIBE

Australia

Job Trends
AstraZeneca PLC Sold Its U.S. HQ But Will Spend $100 Million Expanding Its Australia Facility
July 12, 2017
 · 
1 min read
Let's Get Rid Of Clinical Trials - Part 2
BioMidwest
BioPharm Executive: And So It Continues: Let’s Get Rid of Clinical Trials (Part 2)
July 7, 2017
 · 
4 min read
Drug Development
Bionomics Limited: A Company With Deals On The Horizon
July 5, 2017
 · 
1 min read
Genetown
5 Easy Steps To Generating Quick Job Referrals
July 4, 2017
 · 
1 min read
Genetown
The 3 Most Desirable Skills In The ‘New Breed’ Of Pharma Sales Reps
July 4, 2017
 · 
1 min read
Genetown
‘High Tech’ And Its Impact On Life Science Job Seekers
July 4, 2017
 · 
1 min read
Lone Star Bio
How To Be An Unforgettable Job Applicant
July 4, 2017
 · 
1 min read
Genetown
Avoid These 3 Networking Mistakes Every Unemployed Scientist Makes
July 4, 2017
 · 
1 min read
Biotech Bay
What Matters Most to Life Sciences Professionals?
The opportunity to do interesting and meaningful work is more valuable than money. That’s the consensus of more than 2,400 life science professionals according the 2017 Ideal Employer survey.
July 2, 2017
 · 
3 min read
 · 
Jennifer Fink
3 Under-the-Radar Biotech Clusters for Life Science Job Seekers
Biotech Bay
3 Under-the-Radar Biotech Clusters for Life Science Job Seekers
June 30, 2017
 · 
6 min read
Load More
PRESS RELEASES
Press Releases
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
February 18, 2026
 · 
9 min read
Press Releases
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein (“s-KL”) Isoform of the Human Klotho Gene Sequence
February 18, 2026
 · 
4 min read
Press Releases
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
February 18, 2026
 · 
4 min read
Press Releases
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
February 18, 2026
 · 
10 min read
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
 · 
5 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
 · 
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
 · 
8 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Press Releases
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
February 5, 2026
 · 
2 min read
Press Releases
Telix Full Year Results 2025 Investor Webcast Notification
February 4, 2026
 · 
5 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
 · 
2 min read
Press Releases
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
 · 
6 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
 · 
3 min read
Press Releases
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
 · 
4 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
 · 
7 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
 · 
11 min read
Press Releases
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
February 1, 2026
 · 
12 min read
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
 · 
5 min read
Load More